Khaldon Lweesy

Dr. Khaldon Lweesy


Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 July 2024 in Computers in Biology and Medicine
Verified
Journal Article
Closed access
SAS. Al-Hammouri
S. Al-Hammouri
Rim BarioulRim Barioul
Rim Barioul
KLKhaldon Lweesy
Khaldon Lweesy
MIM. Ibbini
M. Ibbini
Olfa KanounOlfa Kanoun
Olfa Kanoun

29 November 2025 in Journal of Medical Systems
Verified
Journal Article
Closed access
PDF file
KLKhaldon Lweesy
Khaldon Lweesy
SASireen Abuqran
Sireen Abuqran
LFLuay Fraiwan
Luay Fraiwan

5 September 2025 in IEEE Open Journal of Instrumentation and Measurement
Verified
Journal Article
Open access
TATareq Almustafa
Tareq Almustafa
BABilel Ben Atitallah
Bilel Ben Atitallah
KLKhaldon Lweesy
Khaldon Lweesy
MIMohammed Ibbini
Mohammed Ibbini
Olfa KanounOlfa Kanoun
Olfa Kanoun
This study investigates the potential of impedimetric measurements providing deep muscle information for recognizing 36 American Sign Language (ASL) hand signs. Two measurement methods are considered together for the first time: electrical impedance myography (EIM) and electrical impedance tomography (EIT). EIM was measured along the anterior forearm, while 8-electrode EIT was recorded around the forearm below the elbow. Data were acquired from three volunteers, with each hand sign performed ten times. A correlation analysis was conducted to identify the relevant EIM frequencies to distinguish between hand signs. Among all evaluated algorithms, the random forest classifier achieves the highest classification performance. Classification based on the resistance and reactance at the selected EIM frequencies achieved 61.54 ± 0.85%, while classification based on EIT boundary voltages achieved 91.04% ± 0.46%. Combining the results from both classifiers into an EIM-EIT hybrid classifier improved the accuracy to 92.57 ± 0.41%, effectively reducing ambiguities between similar hand signs. Achieved results considerably outperform state-of-the-art works, which typically classify fewer hand signs or achieve lower accuracy.

2 November 2026 in Cancers
Verified
Journal Article
Open access
PDF file
BEBassant El-Mosalamy
Bassant El-Mosalamy
Hossam Magdy BalahaHossam Magdy Balaha
Hossam Magdy Balaha
SESohayla Elmorsi
Sohayla Elmorsi
DGDibson Gondim
Dibson Gondim
KLKhaldon Lweesy
Khaldon Lweesy
Ayman El-BazAyman El-Baz
Ayman El-Baz
The diagnosis of colorectal cancer encompasses nine complementary modalities: stool-based screening, blood-based biomarkers, cross-sectional imaging, endoscopic evaluation, histopathology, liquid biopsy, molecular and genetic profiling, microbiome analysis, and nanotechnology-based diagnostics. This narrative review synthesizes 160 references spanning seven task-specific artificial intelligence domains, including computer-aided detection, optical diagnosis, invasion depth prediction, computational pathology and radiogenomics, metastasis forecasting, neoadjuvant treatment response prediction, and surgical workflow analysis. We propose a conceptual multimodal pipeline comprising data ingestion, preprocessing and harmonization, feature representation, multimodal fusion, forecasting, explainability, and validation. A structured evidence grading framework classifies each clinical task by evidence level, consistency, and clinical readiness. We further catalog public datasets, challenge benchmarks, and five reporting standards: TRIPOD-AI, CONSORT-AI, SPIRIT-AI, DECIDE-AI, and CLAIM. Computer-aided detection and optical diagnosis demonstrate the highest maturity with Level 1 evidence from randomized controlled trials, while computational pathology, radiogenomics, and metastasis prediction remain at Level 2 with retrospective validation (internal or external). Microbiome screening, nanotechnology diagnostics, and surgical phase recognition are exploratory. The principal barriers to clinical adoption are domain shift, data scarcity, calibration, prospective validation, and workflow integration. We conclude that clinically useful artificial intelligence requires robust external validation, uncertainty quantification, explainable outputs, standardized reporting, and a structured translational pathway from retrospective evidence through regulatory clearance to post-deployment monitoring.